Generex appoints chief compliance officer
Title: Generex appoints a CCOGenerex Biotechnology, a biopharmaceutical company, has named Anthony Crisci as general manager, chief compliance officer, and corporate counsel for all of NuGenerex’s distribution efforts.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
PremiumShould Tesla board, compliance rein in Musk? Expert says tech tycoon ‘doubly untouchable’
Tesla’s chief executive Elon Musk has admitted he’s leading his businesses “with great difficulty” while serving as President Trump’s senior adviser. The carmaker’s shareholders are openly questioning his bandwidth. Why isn’t Tesla’s board firing him? He’s “doubly untouchable,” a corporate governance expert says.
-
News BriefCCO who was ‘sole person controlling’ investment firm charged with recidivist concentration violations
An investment company and its founder, president, and chief compliance officer flagrantly kept violating mutual fund rules for multiple years after settling with the Securities and Exchange Commission, the SEC said in a complaint against the company.
-
News BriefFirm, two execs fined, including ex-CCO, for misappropriating $220K, SEC alleges
Two executives at New York-based Momentum Advisors, including the firm’s chief compliance officer, allegedly misappropriated more than $220,000, the Securities and Exchange Commission said.